Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Contineum Therapeutics (CTNM) Shares Issued (2023 - 2026)

Contineum Therapeutics' Shares Issued history spans 4 years, with the latest figure at $198000.0 for Q1 2026.

  • Quarterly Shares Issued rose 725.0% to $198000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $118.6 million through Mar 2026, up 210.39% year-over-year, with the annual reading at $467000.0 for FY2025, 15.31% up from the prior year.
  • Shares Issued came in at $198000.0 for Q1 2026, down from $99.2 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $99.2 million in Q4 2025 to a low of -$107.9 million in Q2 2024.
  • The 4-year median for Shares Issued is $153500.0 (2023), against an average of $954250.0.
  • Year-over-year, Shares Issued crashed 1348650.0% in 2024 and then soared 38499.22% in 2025.
  • Contineum Therapeutics' Shares Issued stood at $159000.0 in 2023, then soared by 61.64% to $257000.0 in 2024, then skyrocketed by 38499.22% to $99.2 million in 2025, then plummeted by 99.8% to $198000.0 in 2026.
  • Per Business Quant, the three most recent readings for CTNM's Shares Issued are $198000.0 (Q1 2026), $99.2 million (Q4 2025), and $19.0 million (Q3 2025).